
|Articles|June 1, 2003
Bimatoprost effective in patients with POAG, hypertension
Author(s)Chet Scerra
Fort Lauderdale, FL-Bimatoprost appears to have greater IOP-lowering effectiveness than travoprost in patients with primary open-angle glaucoma (POAG) or ocular hypertension, according to a small pilot study.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Sandoz Canada launches aflibercept biosimilar, Enzeevum
2
Ocumetics reports first-in-human data investigational accommodating IOL in severe vision loss
3
EnVision Summit 2026: Ultimate gathering place for ophthalmic education
4
AMD and low vision awareness month: Using the MTII to evaluate progression of GA
5




























